Volume : 09, Issue : 07, July – 2022
Title:
64.DILATED CARDIOMYOPATHY WITH HIDDEN PHEOCHROMOCYTOMA
Authors :
Rahat Ahmed Memon, MD, Aisha, Muhammad Amin, Jaffer Ansari, Ghulam Shahar Bano
Abstract :
This report describes the case of a 38-year-old male with a no significant past medical history. The patient presented with the complaints of shortness of breath and episodic headache. In ER, his BP was 138/88 and physical examination was significant for lower lung field crackles and 1+ edema on dorsum of feet. His labs showed increased pro-NT BNP for 1328, CXR with mild to moderate pulmonary edema and cardiomegaly. Transthoracic echocardiogram showed EF of 25% with global hypokinesis. Administration of metoprolol succinate and lisinoprol, increased the systolic BP to 190 and secondary workup for hypertension showed increased plasma metanephrines which was subsequently confirmed by elevated 24-hour urine metanephrines. He had abdominal CT and MRI which showed mass in left adrenal gland. Elective left adrenalectomy yielded an adrenal gland mass which on biopsy confirmed pheochromocytoma.
Cite This Article:
Please cite this article in press Rahat Ahmed Memon et al, Dilated Cardiomyopathy With Hidden Pheochromocytoma.,Indo Am. J. P. Sci, 2022; 09(7). ,
Number of Downloads : 10
References:
REFERENCES:
1. T.Zelinka,O.Petrak,H.Turkova,etal.,Highinciden ceofcardiovascularcomplications in pheochromocytoma, Horm. Metab. Res. 44 (5) (2012) 379–384.
2. R. Yu, N.N. Nissen, S.I. Bannykh, Cardiac complications as initial manifestation of pheochromocytoma: frequency, outcome, and predictors, Endocr. Pract. 18 (4) (2012) 483–492.
3. A.Prejbisz,J.W.Lenders,G.Eisenhofer,A.Janusze wicz,Cardiovascularmanifestations of
phaeochromocytoma, J. Hypertens. 29 (11) (2011) 2049–2060.
4. T.Yoshikawa,Takotsubocardiomyopathy,anewc onceptofcardiomyopathy:clinical features and pathophysiology, Int. J. Cardiol. 182C (2014)
297–303.
5. Sutton MG, Sheps SG, Lie JT: Prevalence of clinically unsus- pected phaeochromocytoma: Review of a 50-year autopsy series. Mayo Clin Proc 56:354-360, 1981
6. Crowley KJ, Cunningham AJ, Conroy B, et al: Phaeochromocy- toma: A presentation mimicking malignant hyperthermia. Anaesthesia 43:1031-
1032, 1988
7. Ross EJ, Griffith DNW: The clinical presentation of phaeochro- mocytoma. Q J Med 266:485-496,
1989
8. Wooster DL, Mitchell RI: Unsuspected phaeochromocytoma presenting during surgery. Can Anaesth Soc J 28:471-474, 1981
9. Prys-Roberts C: Phaeochromocytoma: Recent progress in its management. Br J Anaesth 85:44-
57, 2000
10. Kirkendall WM, Liechty RD, Culp DA: Diagnosis and treatment of patients with pheochromocytoma. Arch Intern Med 115:529-
536, 1965
11. Primak RA, Spicer RD, Variend S: Sudden death after minor abdominal trauma: An unusual presentation of phaeochromocytoma. Br Med J
292:95-96, 1986
12. Bogdonoff DL: Pheochromocytoma: Specialist cases that all must be prepared to treat? J Cardiothorac Vasc Anesth 16:267-269, 2002
13. Quezado ZN, Keiser HR, Parker MM: Reversible myocardial depression after massive catecholamine release from a pheochromocy- toma. Crit Care Med 20:549-551, 1992
14. Wark JD, Larkins RG: Pulmonary edema after propranolol therapy in two cases of phaeochromocytoma. Br Med J 1:1395- 1396,
1978
15. Fahmy N, Assaad M, Bathija P, Whittier FC: Postoperative acute pulmonary edema: A rare presentation of pheochromocytoma. Clin Nephrol
48:122-124, 1997
16. Britain RT, Levy GP: A review of the animal pharmacology of labetalol, a combined beta- adrenoceptor-blocking drug. Br J Phar- macol
3:681, 1976.